✦ LIBER ✦

Corrigendum to “In vivo activity of an azole series of CCR2 antagonists” [Bioorg. Med. Chem. Lett. 22 (2012) 7252–7255]

✍ Scribed by Smethurst, Chris A.; Bevan, Nicola; Brooks, Carl; Emmons, Amanda; Gough, Peter J.; Mookherjee, Claudette; Moores, Kitty; Peace, Simon; Philp, Joanne; Piercy, Val; Watson, Steve P.; Zippoli, Mara

Book ID: 123147556
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 187 KB
Volume: 23
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2012.11.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “Synthesis and antikineto

Corrigendum to “Synthesis and antikinetoplastid activity of a series of N,N′-substituted diamines” [Bioorg. Med. Chem. Lett. 22 (2012) 1712–1715]

✍ Caminos, Andrea P.; Panozzo-Zenere, Esteban A.; Wilkinson, Shane R.; Tekwani, Ba 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Corrigendum to “The design and synthesis

Corrigendum to “The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of Type 2 diabetes mellitus” [Bioorg. Med. Chem. Lett. 22 (2012) 7100–7105]

✍ Pfefferkorn, Jeffrey A.; Tu, Meihua; Filipski, Kevin J.; Guzman-Perez, Angel; Bi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Corrigendum to “Development of an in viv

Corrigendum to “Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostere” [Bioorg. Med. Chem. Lett. 23 (2013) 37–41]

✍ Downey, Jason D.; Saleh, Sam A.; Bridges, Thomas M.; Morrison, Ryan D.; Daniels, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 182 KB